Related Articles
Top Stories
Feb 12 2012 15:59
Moral hazard, financial weapons of mass destruction, a huge mess - these were the words used by a founder member to sum up the collapse of the Pinnacle Point Group.
Feb 12 2012 15:58
Construction companies are now undertaking a second round of self-examination into uncompetitive behaviour.
Feb 12 2012 14:54
American billionaire George Soros has slammed German Chancellor Angela Merkel, warning that her policies could lead to a repeat of the Great Depression.
Berlin - Germany on Tuesday banned a genetically modified strain of corn that the European Union has deemed safe for planting.
Agriculture Minister Ilse Aigner said US seed maker Monsanto's MON810 genetically engineered corn product "presents a danger for the environment."
Genetically modified organisms, or GMOs, are common in the US but controversial in Europe, where activists have protested their use and torn up GMO crops.
In 2004, the European Union authorised the planting of MON810 seeds, which produce a toxin to ward off insects. Monsanto claims this genetic trait precludes the need for dangerous pesticides, but opponents fear the seeds will spread and alter the natural surroundings.
France, Greece, Austria and Hungary have also imposed "safeguard" bans on the MON810 variety, citing studies that find it unsafe to the environment.
In March, EU environment ministers defeated a European Commission proposal that would have forced Austria and Hungary to lift their bans. Germany will join France and Greece in facing scrutiny from the Commission for their bans.
Aigner, a member of the Christian Social Union, the Bavarian sister party of Chancellor Angela Merkel's Christian Democratic Union, had been criticized for caving in to pressure from her heavily agricultural constituency to support the ban.
"Contrary to some assertions, my decision is not a political one," Aigner said.
Environmental groups hailed the decision.
Hubert Weiger, president of the German branch of Friends of the Earth, praised Aigner for "not buckling under pressure from a large biotech company."
- AP